DE60307804T2 - Pyranon- und pyrandioninhibitoren der rna-abhängigen rna-polymerase des hepatitis-c-virus - Google Patents
Pyranon- und pyrandioninhibitoren der rna-abhängigen rna-polymerase des hepatitis-c-virus Download PDFInfo
- Publication number
- DE60307804T2 DE60307804T2 DE60307804T DE60307804T DE60307804T2 DE 60307804 T2 DE60307804 T2 DE 60307804T2 DE 60307804 T DE60307804 T DE 60307804T DE 60307804 T DE60307804 T DE 60307804T DE 60307804 T2 DE60307804 T2 DE 60307804T2
- Authority
- DE
- Germany
- Prior art keywords
- nhc
- group
- compound
- heteroaryl
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *C(CC(*)(*CC#C*)O1)C(*)C1=O Chemical compound *C(CC(*)(*CC#C*)O1)C(*)C1=O 0.000 description 1
- IQJMSUOEGBBRJP-JEUPEJDTSA-N O[C@H](CC(CCC#CC1=CCCC(N=O)=C1)(C1CCCC1)O1)C(Cc2ccccc2)C1=O Chemical compound O[C@H](CC(CCC#CC1=CCCC(N=O)=C1)(C1CCCC1)O1)C(Cc2ccccc2)C1=O IQJMSUOEGBBRJP-JEUPEJDTSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36938102P | 2002-04-01 | 2002-04-01 | |
| US369381P | 2002-04-01 | ||
| PCT/IB2003/001206 WO2003082848A1 (en) | 2002-04-01 | 2003-03-21 | Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60307804D1 DE60307804D1 (de) | 2006-10-05 |
| DE60307804T2 true DE60307804T2 (de) | 2007-01-18 |
Family
ID=28675577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60307804T Expired - Fee Related DE60307804T2 (de) | 2002-04-01 | 2003-03-21 | Pyranon- und pyrandioninhibitoren der rna-abhängigen rna-polymerase des hepatitis-c-virus |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6878727B2 (enExample) |
| EP (1) | EP1490350B1 (enExample) |
| JP (1) | JP2005526102A (enExample) |
| AT (1) | ATE337309T1 (enExample) |
| AU (1) | AU2003215826A1 (enExample) |
| BR (1) | BR0308856A (enExample) |
| CA (1) | CA2480583C (enExample) |
| DE (1) | DE60307804T2 (enExample) |
| ES (1) | ES2268394T3 (enExample) |
| MX (1) | MXPA04009672A (enExample) |
| WO (1) | WO2003082848A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DOP2003000641A (es) * | 2002-05-10 | 2003-11-15 | Pfizer | Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan |
| US7148226B2 (en) * | 2003-02-21 | 2006-12-12 | Agouron Pharmaceuticals, Inc. | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| CN1922174A (zh) | 2004-02-20 | 2007-02-28 | 贝林格尔·英格海姆国际有限公司 | 病毒聚合酶抑制剂 |
| WO2006050035A1 (en) | 2004-10-29 | 2006-05-11 | Schering Corporation | Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| EP1881828A4 (en) * | 2005-05-20 | 2009-06-03 | Valeant Res & Dev | TREATMENT OF HEPATITIS C (HCV) USING SUB-THERAPEUTIC DOSES OF RIBAVIRIN |
| US7816348B2 (en) * | 2006-02-03 | 2010-10-19 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| WO2008047694A1 (fr) * | 2006-10-13 | 2008-04-24 | Aska Pharmaceutical Co., Ltd. | Procédé de fabrication d'un composé benzothiazole |
| MX2009011930A (es) | 2007-05-04 | 2009-11-18 | Vertex Pharma | Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c. |
| WO2009018656A1 (en) * | 2007-08-03 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| WO2009018657A1 (en) * | 2007-08-03 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| EP2234977A4 (en) | 2007-12-19 | 2011-04-13 | Boehringer Ingelheim Int | VIRAL POLYMERASE INHIBITORS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1140049A (en) * | 1977-12-22 | 1983-01-25 | Dke J.E. Helgstran | Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid |
| US6174868B1 (en) * | 1992-09-10 | 2001-01-16 | Isis Pharmaceuticals, Inc. | Compositions and methods for treatment of hepatitis C virus-associated diseases |
| EP0773029A4 (en) * | 1993-07-19 | 1997-09-03 | Tokyo Tanabe Co | HEPATITIS C VIRUS PROLIFERATION INHIBITOR |
| IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
| DE60001218D1 (de) * | 1999-02-22 | 2003-02-20 | Shire Biochem Inc | [1,8]-naphthyridinderivate derivate mit antiviraler wirkung |
| AR034127A1 (es) * | 2000-07-21 | 2004-02-04 | Schering Corp | Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento |
-
2003
- 2003-03-21 AU AU2003215826A patent/AU2003215826A1/en not_active Abandoned
- 2003-03-21 DE DE60307804T patent/DE60307804T2/de not_active Expired - Fee Related
- 2003-03-21 EP EP03745205A patent/EP1490350B1/en not_active Expired - Lifetime
- 2003-03-21 AT AT03745205T patent/ATE337309T1/de not_active IP Right Cessation
- 2003-03-21 WO PCT/IB2003/001206 patent/WO2003082848A1/en not_active Ceased
- 2003-03-21 MX MXPA04009672A patent/MXPA04009672A/es active IP Right Grant
- 2003-03-21 CA CA002480583A patent/CA2480583C/en not_active Expired - Fee Related
- 2003-03-21 ES ES03745205T patent/ES2268394T3/es not_active Expired - Lifetime
- 2003-03-21 BR BR0308856-1A patent/BR0308856A/pt not_active IP Right Cessation
- 2003-03-21 JP JP2003580314A patent/JP2005526102A/ja not_active Abandoned
- 2003-03-31 US US10/403,537 patent/US6878727B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20030195239A1 (en) | 2003-10-16 |
| CA2480583C (en) | 2008-07-15 |
| EP1490350B1 (en) | 2006-08-23 |
| CA2480583A1 (en) | 2003-10-09 |
| BR0308856A (pt) | 2005-02-22 |
| ES2268394T3 (es) | 2007-03-16 |
| EP1490350A1 (en) | 2004-12-29 |
| ATE337309T1 (de) | 2006-09-15 |
| DE60307804D1 (de) | 2006-10-05 |
| US6878727B2 (en) | 2005-04-12 |
| AU2003215826A1 (en) | 2003-10-13 |
| WO2003082848A1 (en) | 2003-10-09 |
| MXPA04009672A (es) | 2004-11-12 |
| JP2005526102A (ja) | 2005-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101930106B1 (ko) | 지질 합성의 헤테로사이클릭 조절자 | |
| US7495018B2 (en) | Substituted 1,3-thiazole compounds, their production and use | |
| DE60224401T2 (de) | Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur | |
| JP6506880B2 (ja) | Ｂ型肝炎ウィルス感染症の治療および予防のための新規な四環式４−オキソ−ピリジン−３−カルボン酸誘導体 | |
| CN102239164B (zh) | 2h-色烯化合物及其衍生物 | |
| US20050080113A1 (en) | Medicinal compositions | |
| TWI522348B (zh) | 脂質合成之雜環調節劑 | |
| EP2455370A1 (en) | Pharmaceutical product containing lactam or benzene sulfonamide compound | |
| US20040063946A1 (en) | Jnk inhibitor | |
| KR20100072075A (ko) | 암 및 골 질환의 치료를 위한 ｃｓｆ-１ｒ 억제제 | |
| WO2002006264A1 (en) | Lipid-rich plaque inhibitors | |
| JP3204901B2 (ja) | Ｎ−（３−ベンゾフラニル）ウレア−誘導体 | |
| KR20100017866A (ko) | Ｃｓｆ－１ｒ 억제제, 조성물 및 사용 방법 | |
| KR102894005B1 (ko) | 항바이러스 1,3-다이-옥소-인덴 화합물 | |
| AU2003202488A1 (en) | Coumarin derivatives, process for their production and use thereof | |
| FR2876692A1 (fr) | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique | |
| TW201124391A (en) | 2-substituted-ethynylthiazole derivatives and uses of same | |
| EP1490350B1 (en) | Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase | |
| JP2002302488A (ja) | 置換１，３−チアゾール化合物、その製造法および用途 | |
| JP2002302445A (ja) | Ｊｎｋ阻害剤 | |
| JP2009523711A (ja) | 新規環状置換フロピリミジン誘導体および心臓血管疾患を処置するためのその使用 | |
| JP2003063993A (ja) | 医薬組成物 | |
| JP2000319166A (ja) | 腸溶製剤 | |
| CN103059042B (zh) | 噻吩类衍生物及其在药学中的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |